Dlh / vlastný kapitál spoločnosti Midatech Pharma Plc
Aká je hodnota metriky Dlh / vlastný kapitál spoločnosti Midatech Pharma Plc?
Hodnota metriky Dlh / vlastný kapitál spoločnosti Midatech Pharma Plc je 0.75
Aká je definícia metriky Dlh / vlastný kapitál?
Dlh / vlastný kapitál (Debt to equity ratio) ukazovateľ vyjadruje pomer vlastného kapitálu a cudzích zdrojov na financovanie majetku spoločnosti.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Dlh / vlastný kapitál spoločností v sektore Health Care sektor na LSE v porovnaní so spoločnosťou Midatech Pharma Plc
Čomu sa venuje spoločnosť Midatech Pharma Plc?
Midatech Pharma plc focuses on the research and development of oncology and rare disease products in the United Kingdom, rest of Europe, and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTX114, an immuno-suppressant for topical application in psoriasis; and MTD211 and MTD219 for central nervous system and transplant anti-rejection indications. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Firmy s metrikou dlh / vlastný kapitál podobnou spoločnosti Midatech Pharma Plc
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Hindustan Tin Works je 0.75
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Signaux Girod S.A je 0.75
- Hodnota metriky Dlh / vlastný kapitál spoločnosti SFC AG je 0.75
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Yamana Gold je 0.75
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Yamana Gold je 0.75
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Hydrofarm je 0.75
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Midatech Pharma Plc je 0.75
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Marathon Oil je 0.75
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Quarterhill je 0.75
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Fidelity National Information Services je 0.75
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Fidelity National Information Services je 0.75
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Applied Industrial Technologies je 0.75
- Hodnota metriky Dlh / vlastný kapitál spoločnosti Panama Petrochem je 0.75